36.7 F
New York
Wednesday, December 2, 2020

Here’s Why Urovant Sciences [NASDAQ: UROV] Is Trading Higher Today?

Must read

Vodafone [NASDAQ: VOD] and RingCentral signs a partnership to provide next-generation services

Vodafone signed a strategic alliance with Ring Central . The association will modify business connections and alliances. The enterprises have joined hands to...

Salesforce [NYSE: CRM] Enters A Deal To Acquire Slack

Salesforce engages in a contract to buy Slack at a worth of $27.7B. This purchase to build an operating system for the...

Xilinx [NASDAQ: XLNX] Announced That It Acquired Falcon Computing

Xilinx Inc. declared that it has purchased falcon Computing Solutions to make flexible computing more accessible and easily adapted by computer programmers. The...

Luokung Corp. [NASDAQ: LKCO] To Acquire EMG For RMB 836 Million

Luokung Technologies Corp. a location-based service company has agreed to buy EMG technologies for Ren Min Bi  836 million. The company will pay...

Shares of Urovant Sciences Ltd. [NASDAQ: UROV] soared 93.24% during the trading session of Friday. The company has disclosed that it has signed a merger agreement with Sumitovant Biopharma.

Sumitovant Biopharma will acquire Urovant Sciences for approximately $584 million in total equity value in an all-cash merger. The shareholders of Urovant Sciences will receive $16.25 per share in cash.

The special committee of the Urovant Board of Directors has approved the offer of Sumitovant Biopharma. The committee has observed that this offer will create exceptional value for the shareholders of Urovant Sciences.

As per the agreement, a wholly-owned subsidiary of Sumitovant will combine with and into Urovant with Urovant to continue the merger as a wholly-owned subsidiary of Sumitovant. Additionally, the deal will be executed after the approval of a majority of minority shareholders.

Urovant Sciences Ltd. [NASDAQ: UROV] shares were trading up 93.24% as it gained +16.00 at the time of writing on Friday. Urovant Sciences Ltd. [UROV] share price went from a low point around $6.55 to briefly over $15.98 in the past 52 weeks, though shares have since pulled back to $16.00. UROV market cap has remained high, hitting $269.60 million at the time of writing.

Agreement between Urovant and Sumitovant is anticipated to be completed in the 2021 quarter one. The company is also planning to introduce vibegron. It has submitted that the New Drug Application for vibegron to FDA. Furthermore, Urovant is projecting to get the approval of the FDA by December 26, 2020.

More articles

Latest article

Nokia [NYSE: NOK] Extends Collaboration With AT&T to Deliver Seamless IoT Connectivity

Nokia Corp. declared that the company has extended its contract with AT&T . The collaboration among the companies can supply and provide an...

Wendy [NASDAQ: WEN] Strikes A Deal With Rebel Foods To Open 250 Cloud Kitchens.

Wendy’s Co. and Rebel foods have partnered to open about 250 cloud kitchens in India. These kitchens will only serve the customer with...

Tesla [NASDAQ: TSLA] Recalls 9537 SUV’s Because Of Manufacturing Issues

Tesla Inc. has released safety recall orders for more than 9500 of its vehicle in the United States. The vehicles include Model Xs...

Northrop [NYSE:NOC] awarded a deal of $4.8B for Global Hawk Aircraft

Northrop Gruman Corp. has been awarded a deal to perform development, transformation, retrofit, and sustenance activities for the Global Hawk Program. This deal...

Athene Enters Into An Agreement With Hertz To Buy Donlen Corp.

Athene Holdings ltd. entered into a deal to buy Donlen corporation from Hertz Global Holdings Inc. Hertz's fully own Donlen Corporation. The stock...

Verizon [NYSE: VZ] Announced to acquire Tracfone for $6.25 billion.

Verizon Communication Inc. declared that it penned down a deal with America Movil to purchase Tracfone for $6.25B. The companies came to terms...

ViacomCBS [NASDAQ: VIAC] Agreed To Sell Simon And Schuster For $2.175 Billion In Cash

ViacomCBS Inc. declared that it entered into an agreement with Penguin Random House LCC to sell Simon and Schuster. It will be sold...

IBM [NYSE: IBM] Plans To Cut Down 20% Of Its Workforce

International business machines Corp. declared that the company is preparing to cut down 10,000 jobs in Europe which makes it’s 20% of the...